More than 8,000 prescriptions electronically filed in the eRx Collaborative system were changed this June as a result of drug-drug or drug-allergy alerts. The eRx Collaborative initiative is a consortium created by Blue Cross Blue Shield of Massachusetts, Tufts Health Plan, and Neighborhood Health Plan to spur e-prescribing in the state. It includes 3,400 prescribers. The 8,000 prescriptions represented 2% of the approximately 400,000 total electronic Rxs filed in June. In fact, as a recent study from the Medical Records Institute noted, avoiding drug allergy was the prime use for e-prescribing, followed closely by access to drug reference information.
More than 8,000 prescriptions electronically filed in the eRx Collaborative system were changed this June as a result of drug-drug or drug-allergy alerts. The eRx Collaborative initiative is a consortium created by Blue Cross Blue Shield of Massachusetts, Tufts Health Plan, and Neighborhood Health Plan to spur e-prescribing in the state. It includes 3,400 prescribers. The 8,000 prescriptions represented 2% of the approximately 400,000 total electronic Rxs filed in June. In fact, as a recent study from the Medical Records Institute noted, avoiding drug allergy was the prime use for e-prescribing, followed closely by access to drug reference information.
UHC to offer debit card
Analysts see bright future for RFID
New on-line eMAR solution
This November, Artromick International will launch a new electronic medication administration record (eMAR) solution specifically designed for long-term care. The Web-based eMAR offers 24/7 data access and features an easy-to-use user-interface. For more information visit: http://www.artromick.com/.
PAR3, Vitality focus on drug adherence
PAR3 Communications and Vitality announced they will partner to focus on improved medication adherence. Together they will monitor how patients are taking medications and deliver personalized patient communications-to include motivational, instructive, and diagnostic messages. The information gathered from Vitality's GlowCap system and PAR3's interactive communications will be aggregated to ensure highly personalized, relevant interventions for patients. More information can be found at: http://www.par3.com/ or http://www.rxvitality.com/.
New and integrated Facts & Comparisons